Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin for Cocaine Use in MSM
NCT03192995Phase 2Terminated
- Start
- Jan 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lorcaserin in cocaine use disorder (CUD). Started Jan 2018; status: terminated.
02
Drugs
lorcaserin
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT03192995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192995.